BioSpace News Archive

Genelux Corporation (NASDAQ: GNLX) and TVAX Biomedical, Inc. today announced that the United States Patent and Trademark Office granted a patent claiming methods of combining vaccine-enhanced adoptive T cell therapy with oncolytic virus adjunct therapy.

Rivus Pharmaceuticals Inc. today announced the appointment of Jayson Dallas, M.D., executive chairman for Rivus Pharmaceuticals, as Chief Executive Officer.

Abbott (NYSE: ABT) will announce its second-quarter 2023 financial results on Thursday, July 20, before the market opens.

Evolus, Inc., a performance beauty company focused on building an aesthetic portfolio, has commenced the commercial launch of Nuceiva® in Italy.

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), a leader in AI-driven biotherapeutic research and technology, today announced that it will host a conference call to discuss its quarterly results and recent business highlights for fourth quarter and fiscal year end 2023, on Friday, July 7, 2023, at 10:30 am Eastern Time.

TScan Therapeutics, Inc. today announced that its Chief Financial Officer, Brian M. Silver, J.D., will be leaving the Company, effective July 21, 2023, to pursue a new opportunity at a leading advisory firm based in New York, where he lives with his family.

Labcorp will release its financial results for the second quarter of 2023 before the market opens on Thursday, July 27, 2023.

Avantor, Inc. announced that it will release its second quarter 2023 financial results before the market opens on Friday, July 28.

Curia, a leading contract research, development and manufacturing organization, announced it has been awarded a Best Practices Customer Value Leadership Award in the CRDMO industry by Frost & Sullivan.

Phenomix Sciences announces the launch of a second of its gut-brain axis phenotyping test, MyPhenome Hungry Brain.